Slide 1: Fourth quarter and full year 2025 results; 2026 financial guidance
Avient Corporation AVNT Fourth quarter and full year 2025 results 2026 financial guidance FEBRUARY 12, 2026
Slide 2: Disclaimer: Forward-looking statements
Disclaimer Forward-looking statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or foreca
Slide 3: Q4 and full year 2025 performance
Q4 and full year 2025 performance Q4 2025 vs. Q4 2024 FULL YEAR 2025 vs. FULL YEAR 2024 Q4 2025 FY 2025 results ORGANIC FX AS results ORGANIC FX AS (excludes impact of REPORTED (excludes impact of REPORTED foreign exchange) foreign exchange) Sales $761M -0.8% 2.7% 1.9% $3,260M -0.3% 0.9% 0.6% Adj. E
Slide 4: Innovation and investments in growth vectors
Innovation and investments in growth vectors Dyneema Non-PFAS materials solutions process innovation GlideTech Cesa polymer processing aids Dyneema • Expanding portfolio of healthcare solutions • Non-PFAS, polymer processing aids for with new non-PFAS and non-silicone lubricious polyolefin films use
Slide 5: Our journey so far, guided by the new strategy
Our journey so far, guided by the new strategy... Adj. EPS Adj. EBITDA margin Adj. ROIC % Net leverage 8.6% 8.3% 3.1x 16.7% $2.82 3.0x 7.7% $2.66 16.2% 16.0% 2.6x $2.36 2023 2024 2025 2023 2024 2025 2023 2024 2025 2023 2024 2025 Adj. ROIC % = Tax-affected Adj. EBITA Net leverage = (Total debt – Cash
Slide 6: 2026: cautiously optimistic but prepared for worse
2026: cautiously optimistic but prepared for worse • Expect macro environment to remain volatile persisting impact from trade policies, geopolitics, and moving supply chains • Anticipate market demand to improve from 2025 levels especially for our CAI business following several government initiative
Slide 7: Q4 2025 segment region results
Q4 2025 segment region results
Slide 8: Color, Additives & Inks – Q4 2025 performance
Color, Additives & Inks – Q4 2025 performance Sales Adj. EBITDA • Improving packaging demand as (0%) (1%) well as growth in healthcare was (3%) (3%) more than offset by organic sales decline in consumer, industrial 82 81 468 and building & construction 466 • Cost reduction actions and productivity i
Slide 9: Specialty Engineered Materials – Q4 2025 performance
Specialty Engineered Materials – Q4 2025 performance Sales Adj. EBITDA • Organic sales growth driven by +6% +10% defense, healthcare and +3% +8% telecommunications 61 296 • Adj. EBITDA margin expansion of 80 bps driven by favorable mix 280 and productivity initiatives more 56 than offsetting investm
Slide 10: Q4 2025 organic revenue growth - by region
Q4 2025 organic revenue growth - by region US & Canada Europe, Middle Asia Latin America East & Africa -1% -2% +3% -5% Year-over-year revenue growth, excludes the impact of foreign exchange Copyright © 2026 . Avient Corporation. All Rights Reserved 10
Slide 11: FY 2025 segment results
FY 2025 segment results
Slide 12: Color, Additives & Inks – FY 2025 performance
Color, Additives & Inks – FY 2025 performance Sales Adj. EBITDA • Organic sales decline primarily (1%) +2% driven by weakness in consumer, (2%) +1% industrial and building & 391 construction partially offset by 2,047 growth in healthcare 2,034 384 • Adj. EBITDA margin expansion of 50 bps driven by f
Slide 13: Specialty Engineered Materials – FY 2025 performance
Specialty Engineered Materials – FY 2025 performance Sales Adj. EBITDA • Organic sales growth driven by +3% +1% capitalizing on secular trends in +2% Flat our high growth end markets, 1,231 252 particularly in healthcare, 249 1,197 defense and telecommunications • Adj. EBITDA margin declined by 40 b
Slide 14: 2026 guidance
2026 guidance
Slide 15: 2026 financial guidance
2026 financial guidance ADJ. EBITDA - full year 2026 ADJ. EPS - full year 2026 Q1 2026 $555 to 585M $2.93 to $3.17 $0.81 +2% to +7% growth +4% to +12% growth adj. EPS guidance MACRO ASSUMPTIONS INFLUENCING RANGE Improvement in Easing interest Continued FX volatility Policy uncertainty Persistent inf
Slide 16: S@AVIENT
oN S@AVIENT
Slide 17: Avient 2025 sales
Avient 2025 sales BUSINESS SEGMENTS END MARKETS REGIONS C AI Telecom Latin America Energy US & Defense Canada 62% 4% 3% Packaging 6% Asia 40% 8% 23% 18% Healthcare 9% Building & 10% construction 18% Consumer 11% 38% Transportation 14% 36% SEM Industrial Europe, Middle East and Africa Copyright © 202
Slide 18: Color, Additives & Inks
Color, Additives & Inks END MARKETS REGIONS Energy 1% Telecom 1% Latin America Transportation 8% 10% Healthcare US & Canada 9% Packaging 33% 35% Asia 20% Building & 11% Construction 15% Industrial 20% 37% Consumer Europe, Middle East and Africa Copyright © 2026 . Avient Corporation. All Rights Reser
Slide 19: Specialty Engineered Materials
Specialty Engineered Materials END MARKETS REGIONS Packaging Telecom Defense Asia 5% 7% 14% Healthcare 22% 8% Energy US & Canada 9% 52% 15% Consumer 34% Building & 9% construction 11% 14% Europe, Transportation Middle East Industrial and Africa Copyright © 2026 . Avient Corporation. All Rights Reser
Slide 20: Avient 2025 regional sales, by end market
Avient 2025 regional sales, by end market U S & C AN AD A EMEA AS I A L AT I N AM E R I C A 40% of sales 36% of sales 18% of sales 6% of sales 2% 1% 1% 3% 1% 5% 5% 5% 6% 13% 11% 6% 12% 25% 10% 33% 7% 5% 19% 5% 12% 10% 10% 20% 13% 61% 12% 13% 13% 13% 9% 15% 24% Packaging Consumer Industrial Transport
Slide 21: Raw material basket
Raw material basket Styrenic block copolymers Polypropylene Performance Nylon additives 5% 4% 16% 5% Polyethylene 8% 14% Pigments Other raw 9% materials TiO2 37% HYDROCARBON-BASED Dyestuffs ~35% of the raw material basket 2% including part of “Other raw materials” NON-HYDROCARBON are hydrocarbon-bas
Slide 22: Reconciliation of Non-GAAP financial measures
Three months ended Dec 31, Reconciliation to condensed Reconciliation of consolidated statements of income $ Millions 2025 EPS (in $) 1 $ Millions 2024 EPS (in $) 1 Non-GAAP financial Net income attributable to Avient common shareholders 16.9 0.18 48.3 0.52 Special items, after-tax 19.3 0.21 (18.0)
Slide 23: Reconciliation of Non-GAAP financial measures
Three months ended Dec 31, Year ended Dec 31, Reconciliation of Reconciliation to EBITDA and Adjusted EBITDA 2025 $ Millions 2024 $ Millions 2025 $ Millions 2024 $ Millions Non-GAAP financial Sales Color, Additives and Inks 466.0 467.7 2,034.2 2,046.5 Specialty Engineered Materials 295.5 279.7 1,231
Slide 24: Reconciliation of Non-GAAP financial measures
Reconciliation of Reconciliation to condensed Year ended Dec 31, 2023 consolidated statements of income $ Millions EPS (in $) 1 Non-GAAP financial Net income from continuing operations attributable to Avient common 75.8 0.83 shareholders Special items, after-tax 79.3 0.86 measures Amortization expen
Slide 25: Reconciliation of Non-GAAP financial measures
Reconciliation of Year ended Dec 31, Adjusted Return on Invested Capital Calculation 2025 2024 2023 Non-GAAP financial $ Millions $ Millions $ Millions EBITA Adj. EBITDA 544.6 526.4 501.8 Tax-affected Depreciation (103.7) (100.4) (107.1) measures adj. earnings before interest, Adj. EBITA 440.9 426.0